Table 1.
Baseline demographic, clinical, and laboratory characteristics of the intervention and control groups (mean (SD)).
| Total (n = 91) |
Intervention (n = 46) |
Control (n = 45) |
p * | |
|---|---|---|---|---|
| Males/ Females [n (%)] | 57/34 (62.6/37.4) | 30/16 (65.2/34.8) |
27/18 (60/40) |
NS |
| Age (years) | 65.12 (10.92) | 64.54 (11.12) |
65.71 (10.82) |
NS |
| Weight (kg) | 92.14 (21.12) | 91.39 (21.7) |
92.92 (20.72) |
NS |
| BMI (kg/m2) | 32.71 (6.91) |
32.11 (6.55) |
33.32 (7.28) |
NS |
| WC (cm) | 110.11 (14.57) | 108.67 (14.6) |
111.58 (14.56) |
NS |
| SBP (mmHg) | 130.02 (13.13) | 128.26 (13.59) |
131.82 (12.54) |
NS |
| DBP (mmHg) | 79.49 (10.72) | 79.26 (11.87) |
79.73 (9.52) |
NS |
| FBG (mmol/L) | 7.62 (1.32) |
7.54 (1.22) |
7.69 (1.43) |
NS |
| HbA1c (%) | 7.28 (0.50) |
7.24 (0.49) |
7.32 (0.52) |
NS |
| TC (mmol/L) | 3.94 (0.77) |
3.88 (0.76) |
4.01 (0.79) |
NS |
| Trig (mmol/L) | 1.47 (0.47) |
1.44 (0.51) |
1.51 (0.43) |
NS |
| HDL-C (mmol/L) | 1.13 (0.29) |
1.14 (0.30) |
1.11 (0.28) |
NS |
| LDL-C (mmol/L) | 2.16 (0.67) |
2.08 (0.57) |
2.25 (0.76) |
NS |
| Creatin (umol/L) | 80.46 (23.87) | 84.88 (26.53) |
76.93 (19.45) |
NS |
| AST (U/L) | 19.95 (6.95) |
20.30 (5.61) |
19.58 (8.14) |
NS |
| ALT (U/L) | 21.42 (9.67) |
21.41 (6.92) |
21.43 (11.93) |
NS |
| γGT (U/L) | 21.60 (11.58) | 20.69 (10.63) |
22.53 (12.53) |
NS |
| Alk Phos (U/L) | 65.85 (24.28) | 64.60 (18.67) |
67.13 (29.44) |
NS |
* Comparison between intervention and control groups; NS = not significant. BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose; HbA1c: glycated hemoglobin; TC: total cholesterol; Trig: triglycerides, HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; Creatin: creatinine; AST: aspartate aminotransferase; ALT: alanine aminotransferase; γGT: γ-glutamyl-transferase; Alk Phos: alkaline phosphatase.